메뉴 건너뛰기




Volumn 10, Issue , 2010, Pages

Protein expression profile and prevalence pattern of the molecular classes of breast cancer - a Saudi population based study

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 5; CYTOKERATIN 6; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; PROTEIN P53; EGFR PROTEIN, HUMAN; HER2 PROTEIN, HUMAN; KRT5 PROTEIN, HUMAN; TP53 PROTEIN, HUMAN; TUMOR MARKER; TUMOR PROTEIN;

EID: 77952441811     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-223     Document Type: Article
Times cited : (65)

References (58)
  • 1
    • 33747148458 scopus 로고    scopus 로고
    • Breast cancer trends among young women in the United States
    • 10.1097/01.ede.0000229195.98786.ee, 16804474
    • Tarone RE. Breast cancer trends among young women in the United States. Epidemiology 2006, 17(5):588-590. 10.1097/01.ede.0000229195.98786.ee, 16804474.
    • (2006) Epidemiology , vol.17 , Issue.5 , pp. 588-590
    • Tarone, R.E.1
  • 3
    • 38949213432 scopus 로고    scopus 로고
    • Cancer Incidence Report Saudi Arabia 2002
    • Registry NC. Cancer Incidence Report Saudi Arabia 2002. Riyadh 2007,
    • (2007) Riyadh
    • Registry, N.C.1
  • 5
    • 0032776863 scopus 로고    scopus 로고
    • Locally advanced breast cancer in Saudi Arabia: high frequency of stage III in a young population
    • Ezzat AA, Ibrahim EM, Raja MA, Al-Sobhi S, Rostom A, Stuart RK. Locally advanced breast cancer in Saudi Arabia: high frequency of stage III in a young population. Med Oncology 1999, 16(2):95-103.
    • (1999) Med Oncology , vol.16 , Issue.2 , pp. 95-103
    • Ezzat, A.A.1    Ibrahim, E.M.2    Raja, M.A.3    Al-Sobhi, S.4    Rostom, A.5    Stuart, R.K.6
  • 6
    • 34249095430 scopus 로고    scopus 로고
    • New generation of molecular prognostic and predictive tests for breast cancer
    • 10.1053/j.seminoncol.2007.03.015, 17512431
    • Pusztai L, Cristofanilli M, Paik S. New generation of molecular prognostic and predictive tests for breast cancer. Semin Oncol 2007, 34(2 Suppl 3):S10-6. 10.1053/j.seminoncol.2007.03.015, 17512431.
    • (2007) Semin Oncol , vol.34 , Issue.2 SUPPL. 3
    • Pusztai, L.1    Cristofanilli, M.2    Paik, S.3
  • 7
    • 33748578365 scopus 로고    scopus 로고
    • Molecular classification of breast cancer: limitations and potential
    • 10.1634/theoncologist.11-8-868, 16951390
    • Pusztai L, Mazouni C, Anderson K, Wu Y, Symmans WF. Molecular classification of breast cancer: limitations and potential. Oncologist 2006, 11(8):868-877. 10.1634/theoncologist.11-8-868, 16951390.
    • (2006) Oncologist , vol.11 , Issue.8 , pp. 868-877
    • Pusztai, L.1    Mazouni, C.2    Anderson, K.3    Wu, Y.4    Symmans, W.F.5
  • 9
    • 0035868668 scopus 로고    scopus 로고
    • Update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology
    • Bast RC, Ravdin P, Hayes DF, Bates S, Fritsche H, Jessup JM, Kemeny N, Locker GY, Mennel RG, Somerfield MR. Update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001, 19:1865-1878.
    • (2001) J Clin Oncol , vol.19 , pp. 1865-1878
    • Bast, R.C.1    Ravdin, P.2    Hayes, D.F.3    Bates, S.4    Fritsche, H.5    Jessup, J.M.6    Kemeny, N.7    Locker, G.Y.8    Mennel, R.G.9    Somerfield, M.R.10
  • 15
    • 22244449596 scopus 로고    scopus 로고
    • Highthroughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses
    • 10.1002/ijc.21004, 15818618
    • Abd El-Rehim DM, Ball G, Pinder SE, Rakha E, Paish C, Robertson JF, Macmillan D, Blamey RW, Ellis IO. Highthroughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses. Int J Cancer 2005, 116:340-350. 10.1002/ijc.21004, 15818618.
    • (2005) Int J Cancer , vol.116 , pp. 340-350
    • Abd El-Rehim, D.M.1    Ball, G.2    Pinder, S.E.3    Rakha, E.4    Paish, C.5    Robertson, J.F.6    Macmillan, D.7    Blamey, R.W.8    Ellis, I.O.9
  • 20
    • 67149146200 scopus 로고    scopus 로고
    • Prevalence, Morphologic Features and Proliferation Indices of Breast Carcinoma Molecular Classes Using Immunohistochemical Surrogate Markers
    • 2655155, 19294003
    • Bhargava R, Striebel J, Beriwal S, Flickinger JC, Onisko A, Ahrendt G, Dabbs DJ. Prevalence, Morphologic Features and Proliferation Indices of Breast Carcinoma Molecular Classes Using Immunohistochemical Surrogate Markers. Int J clin Exp Pathol 2009, 444-455. 2655155, 19294003.
    • (2009) Int J clin Exp Pathol , pp. 444-455
    • Bhargava, R.1    Striebel, J.2    Beriwal, S.3    Flickinger, J.C.4    Onisko, A.5    Ahrendt, G.6    Dabbs, D.J.7
  • 22
    • 24044520039 scopus 로고    scopus 로고
    • EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations
    • 10.1038/modpathol.3800438, 15920544
    • Bhargava R, Gerald WL, Li AR, Pan Q, Lal P, Ladanyi M, Chen B. EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations. Modern Pathology 2005, 18:1027-1033. 10.1038/modpathol.3800438, 15920544.
    • (2005) Modern Pathology , vol.18 , pp. 1027-1033
    • Bhargava, R.1    Gerald, W.L.2    Li, A.R.3    Pan, Q.4    Lal, P.5    Ladanyi, M.6    Chen, B.7
  • 24
    • 0032158664 scopus 로고    scopus 로고
    • Study of Ki 67 immunoreactivity as a prognostic indicator in patients with advanced gastric cancer
    • 10.1093/jjco/28.9.534, 9793024
    • De Manzoni G, Verlato G, Tomezzoli A. Study of Ki 67 immunoreactivity as a prognostic indicator in patients with advanced gastric cancer. Jpn J Clin Oncol 1998, 28:534-537. 10.1093/jjco/28.9.534, 9793024.
    • (1998) Jpn J Clin Oncol , vol.28 , pp. 534-537
    • De Manzoni, G.1    Verlato, G.2    Tomezzoli, A.3
  • 25
    • 0035082615 scopus 로고    scopus 로고
    • Pathologic, Immunohistochemical, and Molecular Features of Benign and Malignant Phyllodes Tumors of the Breast
    • Kleer CG, Giordano TJ, Braun T, Oberman HA. Pathologic, Immunohistochemical, and Molecular Features of Benign and Malignant Phyllodes Tumors of the Breast. Mod Pathol 2000, 14(3):185-190.
    • (2000) Mod Pathol , vol.14 , Issue.3 , pp. 185-190
    • Kleer, C.G.1    Giordano, T.J.2    Braun, T.3    Oberman, H.A.4
  • 27
    • 33747819585 scopus 로고    scopus 로고
    • Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and HER2/neu-overexpressing phenotypes
    • 10.1016/j.humpath.2006.04.015, 16938528
    • Kim MJ, Ro JY, Ahn SH, Kim HH, Kim SB, Gong G. Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and HER2/neu-overexpressing phenotypes. Hum Pathol 2006, 37(9):1217-1226. 10.1016/j.humpath.2006.04.015, 16938528.
    • (2006) Hum Pathol , vol.37 , Issue.9 , pp. 1217-1226
    • Kim, M.J.1    Ro, J.Y.2    Ahn, S.H.3    Kim, H.H.4    Kim, S.B.5    Gong, G.6
  • 29
    • 44849091240 scopus 로고    scopus 로고
    • Prognostic ability of a panel of immunohistochemistry markers - retailoring of an 'old solution'
    • 10.1186/bcr1854, 2374964, 18331621
    • Brennan DJ, Gallagher WM. Prognostic ability of a panel of immunohistochemistry markers - retailoring of an 'old solution'. Breast Cancer Res 2008, 10(1):102. 10.1186/bcr1854, 2374964, 18331621.
    • (2008) Breast Cancer Res , vol.10 , Issue.1 , pp. 102
    • Brennan, D.J.1    Gallagher, W.M.2
  • 30
    • 77953911568 scopus 로고    scopus 로고
    • A synthetic review of the five molecular Sorlie's subtypes in breast cancer
    • Guedj M. A synthetic review of the five molecular Sorlie's subtypes in breast cancer. , http://mickael.guedj.googlepages.com/mguedjCITReview01.pdf
    • Guedj, M.1
  • 31
    • 70449556899 scopus 로고    scopus 로고
    • The immunohistochemically "ER-negative, PR-negative, HER2-negative, CK5/6-negative, and HER1-negative" subgroup is not a surrogate for the normal-like subtype in breast cancer
    • 10.1007/s10549-009-0522-y, 19714461
    • Yu KD, Shen ZZ, Shao ZM. The immunohistochemically "ER-negative, PR-negative, HER2-negative, CK5/6-negative, and HER1-negative" subgroup is not a surrogate for the normal-like subtype in breast cancer. Breast Cancer Res Treat 2009, 118(3):661-663. 10.1007/s10549-009-0522-y, 19714461.
    • (2009) Breast Cancer Res Treat , vol.118 , Issue.3 , pp. 661-663
    • Yu, K.D.1    Shen, Z.Z.2    Shao, Z.M.3
  • 32
    • 23844549918 scopus 로고    scopus 로고
    • Breast cancer molecular subtypes respond differently to preoperative chemotherapy
    • 10.1158/1078-0432.CCR-04-2421, 16115903
    • Rouzier R, Perou CM, Symmans WF, Ibrahim N, Cristofanilli M, Anderson K, et al. Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res 2005, 11(16):5678-5685. 10.1158/1078-0432.CCR-04-2421, 16115903.
    • (2005) Clin Cancer Res , vol.11 , Issue.16 , pp. 5678-5685
    • Rouzier, R.1    Perou, C.M.2    Symmans, W.F.3    Ibrahim, N.4    Cristofanilli, M.5    Anderson, K.6
  • 34
    • 48249134048 scopus 로고    scopus 로고
    • Factors predictive of response to hormone therapy in breast cancer
    • Rastelli F, Crispino S. Factors predictive of response to hormone therapy in breast cancer. Tumori 2008, 94(3):370-383.
    • (2008) Tumori , vol.94 , Issue.3 , pp. 370-383
    • Rastelli, F.1    Crispino, S.2
  • 35
    • 33748071468 scopus 로고    scopus 로고
    • High progesterone receptor expression correlates to the effect of adjuvant tamoxifen in premenopausal breast cancer patients
    • 10.1158/1078-0432.CCR-06-0248, 16899609
    • Stendahl M, Rydén L, Nordenskjöld B, Jönsson PE, Landberg G, Jirström K. High progesterone receptor expression correlates to the effect of adjuvant tamoxifen in premenopausal breast cancer patients. Clin Cancer Res 2006, 12(15):4614-4618. 10.1158/1078-0432.CCR-06-0248, 16899609.
    • (2006) Clin Cancer Res , vol.12 , Issue.15 , pp. 4614-4618
    • Stendahl, M.1    Rydén, L.2    Nordenskjöld, B.3    Jönsson, P.E.4    Landberg, G.5    Jirström, K.6
  • 36
    • 17144369986 scopus 로고    scopus 로고
    • Concurrent (CAFT) versus sequential (CAF-T) chemohormonal therapy (cyclophosphamide, doxorubicin, 5-fluorouracil, tamoxifen) versus T alone for postmenopausal, estrogen (ER) and/or progesterone (PR) receptor-positive breast cancer: Mature outcomes and new biologic correlates on phase III intergroup trial 0100 (SWOG-8814)
    • (abstract 37), for the breast cancer intergroup of North America
    • Albain K, Barlow W, O'Malley F, Siziopikou K, Yeh IT, Ravdin P, Lew D, Farrar W, Burton G, Ketchel S, , et al. for the breast cancer intergroup of North America Concurrent (CAFT) versus sequential (CAF-T) chemohormonal therapy (cyclophosphamide, doxorubicin, 5-fluorouracil, tamoxifen) versus T alone for postmenopausal, estrogen (ER) and/or progesterone (PR) receptor-positive breast cancer: Mature outcomes and new biologic correlates on phase III intergroup trial 0100 (SWOG-8814). Breast Cancer Res Treat 2004, 88:S20. (abstract 37), for the breast cancer intergroup of North America.
    • (2004) Breast Cancer Res Treat , vol.88
    • Albain, K.1    Barlow, W.2    O'Malley, F.3    Siziopikou, K.4    Yeh, I.T.5    Ravdin, P.6    Lew, D.7    Farrar, W.8    Burton, G.9    Ketchel, S.10
  • 37
    • 63249095994 scopus 로고    scopus 로고
    • Predicting endocrine therapy responsiveness in breast cancer
    • Ma CX, Sanchez CG, Ellis MJ. Predicting endocrine therapy responsiveness in breast cancer. Oncology 2009, 2:133-142.
    • (2009) Oncology , vol.2 , pp. 133-142
    • Ma, C.X.1    Sanchez, C.G.2    Ellis, M.J.3
  • 38
    • 33646198056 scopus 로고    scopus 로고
    • Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status
    • 10.1093/annonc/mdl016, 16497822
    • Dowsett M, Houghton J, Iden C, Salter J, Farndon J, A'Hern R, Sainsbury R, Baum M. Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status. Ann Oncol 2006, 17(5):818-826. 10.1093/annonc/mdl016, 16497822.
    • (2006) Ann Oncol , vol.17 , Issue.5 , pp. 818-826
    • Dowsett, M.1    Houghton, J.2    Iden, C.3    Salter, J.4    Farndon, J.5    A'Hern, R.6    Sainsbury, R.7    Baum, M.8
  • 39
    • 77953913986 scopus 로고    scopus 로고
    • Integrated profiling of basal and luminal breast cancers
    • Adelaide J. Integrated profiling of basal and luminal breast cancers. Cancer Research 2007, 7:231.
    • (2007) Cancer Research , vol.7 , pp. 231
    • Adelaide, J.1
  • 40
    • 0030060718 scopus 로고    scopus 로고
    • Prognostic signifi cance of tumor cell proliferation rate as determined by the MIB-1 antibody in breast carcinoma: its relationship with vimentin and p53 protein
    • Domagala W, Markiewski M, Harezga B, Dukowicz A, Osborn M. Prognostic signifi cance of tumor cell proliferation rate as determined by the MIB-1 antibody in breast carcinoma: its relationship with vimentin and p53 protein. Clin Cancer Res 1996, 2(1):147-154.
    • (1996) Clin Cancer Res , vol.2 , Issue.1 , pp. 147-154
    • Domagala, W.1    Markiewski, M.2    Harezga, B.3    Dukowicz, A.4    Osborn, M.5
  • 41
    • 20244374922 scopus 로고    scopus 로고
    • Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors -- a surrogate marker?
    • 10.1002/cncr.11188, 12599241, International Breast Cancer Study Group
    • Trihia H, Murray S, Price K, Gelber RD, Golouh R, Goldhirsch A, Coates AS, Collins J, Castiglione-Gertsch M, Gusterson BA, . International Breast Cancer Study Group Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors -- a surrogate marker?. Cancer 2003, 97(5):1321-1331. 10.1002/cncr.11188, 12599241, International Breast Cancer Study Group.
    • (2003) Cancer , vol.97 , Issue.5 , pp. 1321-1331
    • Trihia, H.1    Murray, S.2    Price, K.3    Gelber, R.D.4    Golouh, R.5    Goldhirsch, A.6    Coates, A.S.7    Collins, J.8    Castiglione-Gertsch, M.9    Gusterson, B.A.10
  • 44
    • 33846965616 scopus 로고    scopus 로고
    • Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer
    • 10.1093/jnci/djk020, 17228000, IMPACT Trialists Group
    • Dowsett M, Smith IE, Ebbs SR, Dixon JM, Skene A, A'Hern R, Salter J, Detre S, Hills M, Walsh G, . IMPACT Trialists Group Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer. J Natl Cancer Inst 2007, 99(2):167-170. 10.1093/jnci/djk020, 17228000, IMPACT Trialists Group.
    • (2007) J Natl Cancer Inst , vol.99 , Issue.2 , pp. 167-170
    • Dowsett, M.1    Smith, I.E.2    Ebbs, S.R.3    Dixon, J.M.4    Skene, A.5    A'Hern, R.6    Salter, J.7    Detre, S.8    Hills, M.9    Walsh, G.10
  • 45
    • 0029039796 scopus 로고
    • Proliferation markers in breast carcinoma. Mitotic figure count, S-phase fraction, proliferating cell nuclear antigen, Ki-67 and MIB-1
    • Keshgegian AA, Cnaan A. Proliferation markers in breast carcinoma. Mitotic figure count, S-phase fraction, proliferating cell nuclear antigen, Ki-67 and MIB-1. Am J Clin Pathol 1995, 104(1):42-49.
    • (1995) Am J Clin Pathol , vol.104 , Issue.1 , pp. 42-49
    • Keshgegian, A.A.1    Cnaan, A.2
  • 46
    • 0030050238 scopus 로고    scopus 로고
    • Lack of prognostic significance of the monoclonal antibody Ki-S1, a novel marker of proliferative activity, in node-negative breast carcinoma
    • 10.1007/BF01806494, 8750580
    • Bevilacqua P, Verderio P, Barbareschi M, Bonoldi E, Boracchi P, Dalla Palma P, Gasparini G. Lack of prognostic significance of the monoclonal antibody Ki-S1, a novel marker of proliferative activity, in node-negative breast carcinoma. Breast Cancer Res Treat 1996, 37(2):123-133. 10.1007/BF01806494, 8750580.
    • (1996) Breast Cancer Res Treat , vol.37 , Issue.2 , pp. 123-133
    • Bevilacqua, P.1    Verderio, P.2    Barbareschi, M.3    Bonoldi, E.4    Boracchi, P.5    Dalla Palma, P.6    Gasparini, G.7
  • 47
    • 0033180397 scopus 로고    scopus 로고
    • The utility of mitotic index, oestrogen receptor and Ki-67 measurements in the creation of novel prognostic indices for node-negative breast cancer
    • 10.1053/ejso.1999.0657, 10419704
    • Clahsen PC, Velde CJ, Duval C, Pallud C, Mandard AM, Delobelle-Deroide A, Broek L, Vijver MJ. The utility of mitotic index, oestrogen receptor and Ki-67 measurements in the creation of novel prognostic indices for node-negative breast cancer. Eur J Surg Oncol 1999, 25(4):356-363. 10.1053/ejso.1999.0657, 10419704.
    • (1999) Eur J Surg Oncol , vol.25 , Issue.4 , pp. 356-363
    • Clahsen, P.C.1    Velde, C.J.2    Duval, C.3    Pallud, C.4    Mandard, A.M.5    Delobelle-Deroide, A.6    Broek, L.7    Vijver, M.J.8
  • 48
    • 0037341394 scopus 로고    scopus 로고
    • Amplification of erbB2 and erbB2 expression are superior to estrogen receptor status as risk factors for distant recurrence in pT1N0M0 breast cancer: a nationwide population based study
    • Joensuu H, Isola J, Lundin M, Salminen T, Holli K, Kataja V, Pylkkänen L, Turpeenniemi-Hujanen T, von Smitten K, Lundin J. Amplification of erbB2 and erbB2 expression are superior to estrogen receptor status as risk factors for distant recurrence in pT1N0M0 breast cancer: a nationwide population based study. Clin Cancer Res 2003, 9(3):923-930.
    • (2003) Clin Cancer Res , vol.9 , Issue.3 , pp. 923-930
    • Joensuu, H.1    Isola, J.2    Lundin, M.3    Salminen, T.4    Holli, K.5    Kataja, V.6    Pylkkänen, L.7    Turpeenniemi-Hujanen, T.8    von Smitten, K.9    Lundin, J.10
  • 49
    • 0034051625 scopus 로고    scopus 로고
    • The prognostic value of proliferation indices: a study with in vivo bromodeoxyuridine and Ki-67
    • 10.1023/A:1006344010050, 10817346
    • Goodson WH, Moore DH, Ljung BM, Chew K, Mayall B, Smith HS, Waldman FM. The prognostic value of proliferation indices: a study with in vivo bromodeoxyuridine and Ki-67. Breast Cancer Res Treat 2000, 59(2):113-123. 10.1023/A:1006344010050, 10817346.
    • (2000) Breast Cancer Res Treat , vol.59 , Issue.2 , pp. 113-123
    • Goodson, W.H.1    Moore, D.H.2    Ljung, B.M.3    Chew, K.4    Mayall, B.5    Smith, H.S.6    Waldman, F.M.7
  • 53
    • 15444379488 scopus 로고    scopus 로고
    • Immunohistochemical detection of Ki67 in breast cancer correlates with transcriptional regulation of genes related to apoptosis and cell death
    • 10.1038/modpathol.3800254, 15578079
    • Tan PH, Bay BH, Yip G, Selvarajan S, Tan P, Wu J, Lee CH, Li KB. Immunohistochemical detection of Ki67 in breast cancer correlates with transcriptional regulation of genes related to apoptosis and cell death. Mod Pathol 2005, 18(3):374-381. 10.1038/modpathol.3800254, 15578079.
    • (2005) Mod Pathol , vol.18 , Issue.3 , pp. 374-381
    • Tan, P.H.1    Bay, B.H.2    Yip, G.3    Selvarajan, S.4    Tan, P.5    Wu, J.6    Lee, C.H.7    Li, K.B.8
  • 54
    • 55949125292 scopus 로고    scopus 로고
    • Basal cytokeratin expression in relation to biological factors in breast cancer
    • 10.1016/j.humpath.2008.06.007, 18755493
    • Kuroda H, Ishida F, Nakai M, Ohnisi K, Itoyama S. Basal cytokeratin expression in relation to biological factors in breast cancer. Hum Pathol 2008, 39(12):1744-1750. 10.1016/j.humpath.2008.06.007, 18755493.
    • (2008) Hum Pathol , vol.39 , Issue.12 , pp. 1744-1750
    • Kuroda, H.1    Ishida, F.2    Nakai, M.3    Ohnisi, K.4    Itoyama, S.5
  • 55
    • 33846587923 scopus 로고    scopus 로고
    • The basal subtype of breast carcinomas may represent the group of breast tumors that could benefit from EGFR-targeted therapies
    • 10.1016/j.breast.2006.09.003, 17097880
    • Siziopikou KP, Cobleigh M. The basal subtype of breast carcinomas may represent the group of breast tumors that could benefit from EGFR-targeted therapies. Breast 2007, 16(1):104-107. 10.1016/j.breast.2006.09.003, 17097880.
    • (2007) Breast , vol.16 , Issue.1 , pp. 104-107
    • Siziopikou, K.P.1    Cobleigh, M.2
  • 56
    • 52049086689 scopus 로고    scopus 로고
    • Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer
    • 10.1200/JCO.2008.16.6231, 18779615
    • Atchley DP, Albarracin CT, Lopez A, Valero V, Amos CI, Gonzalez-Angulo AM, Hortobagyi GN, Arun BK. Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer. J Clin Oncol 2008, 26(26):4282-4288. 10.1200/JCO.2008.16.6231, 18779615.
    • (2008) J Clin Oncol , vol.26 , Issue.26 , pp. 4282-4288
    • Atchley, D.P.1    Albarracin, C.T.2    Lopez, A.3    Valero, V.4    Amos, C.I.5    Gonzalez-Angulo, A.M.6    Hortobagyi, G.N.7    Arun, B.K.8
  • 57
    • 70349169955 scopus 로고    scopus 로고
    • ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approaches
    • Chen JQ, Russo J. ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approaches. Biochim Biophys Acta 2009, 1796(2):162-175.
    • (2009) Biochim Biophys Acta , vol.1796 , Issue.2 , pp. 162-175
    • Chen, J.Q.1    Russo, J.2
  • 58
    • 43549104712 scopus 로고    scopus 로고
    • Basal carcinoma of the breast revisited: an old entity with new interpretations
    • 10.1136/jcp.2008.055475, 18326009
    • Korsching E, Jeffrey SS, Meinerz W, Decker T, Boecker W, Buerger H. Basal carcinoma of the breast revisited: an old entity with new interpretations. J Clin Pathol 2008, 61:553-60. 10.1136/jcp.2008.055475, 18326009.
    • (2008) J Clin Pathol , vol.61 , pp. 553-560
    • Korsching, E.1    Jeffrey, S.S.2    Meinerz, W.3    Decker, T.4    Boecker, W.5    Buerger, H.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.